Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Public ClinicalTrials.gov record NCT07631637. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will test a Regeneron study drug called ALN-CIDEB to find out whether it may help treat a liver disease called MASH. In this study, researchers are looking at the effect of ALN-CIDEB on reducing liver fat, liver injury, and liver scarring. The study will compare ALN-CIDEB with placebo to understand how well ALN-CIDEB works to lower the amount of fat in the liver. The study is looking at: * What side effects ALN-CIDEB might cause * How well ALN-CIDEB works to change liver fat, liver injury, and liver scarring * How the body and the liver change after having ALN-CIDEB, which can help researchers understand why ALN-CIDEB works better for some people than others
Study identification
- NCT ID
- NCT07631637
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 150 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 6, 2026 (Actual)
- Primary completion
- Jan 29, 2029 (Estimated)
- Completion
- Jan 29, 2029 (Estimated)
- Last update posted
- Oct 26, 2026
2026 – 2029
United States locations
- U.S. sites
- 15
- U.S. states
- 5
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Adobe Clinical Research | Tucson | Arizona | 85712 | Recruiting |
| The Institute for Liver Health II LLC dba Arizona Liver Health | Tucson | Arizona | 85712 | Recruiting |
| Del Sol Research Management, LLC | Tucson | Arizona | 85715 | Recruiting |
| California Liver Research Institute | Pasadena | California | 91105 | Recruiting |
| Inland Empire Clinical Trials | Rialto | California | 92377 | Recruiting |
| Universal Axon Clinical Research | Doral | Florida | 33166 | Recruiting |
| Genoma Research Group, Inc. | Miami | Florida | 33173 | Recruiting |
| Med Research of Florida, LLC | Miami | Florida | 33186 | Recruiting |
| Tandem Clinical Research | Marrero | Louisiana | 70072 | Recruiting |
| Tandem Clinical Research | Metairie | Louisiana | 70006 | Recruiting |
| American Research Corporation | Austin | Texas | 78757 | Recruiting |
| Advanced Medical Trials | Georgetown | Texas | 78628 | Recruiting |
| Pioneer Research Solutions, Inc. | Houston | Texas | 77099 | Recruiting |
| American Research Corporation at The Texas Liver Institute | San Antonio | Texas | 78215 | Recruiting |
| Siena Research Network | Sugar Land | Texas | 77479 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07631637, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 26, 2026 · Synced Nov 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07631637 live on ClinicalTrials.gov.